‘Connecting Drug Delivery’ magazine features Nemera’s article about connected devices for patients’ needs.
The recently published ‘Connecting Drug Delivery’ magazine includes an article from Nemera: “Connected Devices – Medication Delivery Just Got Personal”.
In this article, Thierry Decock, Device Development Leader, and Hadrien Gremillet, Senior Marketing Analyst, both of Nemera, explore how the obstacles to the adoption of connectivity can be overcome and how connected devices can deliver truly patient-centric care.
Personalization has become an essential component in people’s everyday lives and technology is a key enabler of the ability of drug delivery device and pharma companies to deliver that level of personalization.
A low patient adherence is a substantial problem causing significant yet avoidable healthcare costs. Connected devices can be one of the solution to this problem but there is still some barriers to the implantation of such technology remain.
Nemera has already developed proof-of-principle connected devices for nasal and ophthalmic drug delivery as well as injection. The company has invested in connected and smart devices based on the strong belief that the technology directly benefits patients by improving adherence.
The full article:
The full issue of the magazine:
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.